ERVEBO 72000000 [PFU]/mL
ZAIRE EBOLAVIRUS (STRAIN KIKWIT-95) ENVELOPE GLYCOPROTEIN · INJECTION, SOLUTION · Merck Sharp & Dohme LLC
Ervebo is a vaccine that protects against Zaire ebolavirus infection and is given as an injection into the muscle. It is available as an over-the-counter vaccine for people at risk of exposure to Ebola virus.
Key Facts
- Brand Name
- ERVEBO
- Generic Name
- ZAIRE EBOLAVIRUS (STRAIN KIKWIT-95) ENVELOPE GLYCOPROTEIN
- NDC Code (Product)
0006-4293- Manufacturer
- Merck Sharp & Dohme LLC
- Strength
- 72000000 [PFU]/mL
- Dosage Form
- INJECTION, SOLUTION
- Route
- INTRAMUSCULAR
- Marketing Status
- Application #
- BLA125690
- Marketing Start
- 12/19/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is ERVEBO used for?
Ervebo is a vaccine that protects against Zaire ebolavirus infection and is given as an injection into the muscle. It is available as an over-the-counter vaccine for people at risk of exposure to Ebola virus.
Is ERVEBO a controlled substance?
ERVEBO is not classified as a controlled substance by the DEA.
What is the generic name for ERVEBO?
The generic name for ERVEBO is ZAIRE EBOLAVIRUS (STRAIN KIKWIT-95) ENVELOPE GLYCOPROTEIN. There are no other listed brand versions of ZAIRE EBOLAVIRUS (STRAIN KIKWIT-95) ENVELOPE GLYCOPROTEIN.
What is the NDC code for ERVEBO 72000000 [PFU]/mL?
The NDC (National Drug Code) for ERVEBO 72000000 [PFU]/mL is 0006-4293, listed by Merck Sharp & Dohme LLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)